NOTCH4 and head and neck squamous cell carcinoma: Like NOTCH1, the NOTCH4 signalling pathway can also be over-activated in HNSCC, resulting in an increase in cellular resistance to cisplatin, accompanied by increased EMT characteristics, higher invasive potential, and acceleration of proliferation [93].